// App-Quantinova.ai

: A Clinical Trial Evaluating the Effects of Ultra-Violet C treatment (UVC) during Ex Vivo Lung Perfusion (EVLP) as a Method of Inactivating Hepatitis C Infection in Donor Lungs

Researchers

Presenter

  • M. Cypel

Principal Investigators

  • M. Galasso

  • R. Ribeiro

  • B. Wilson

  • V. Bagnato

  • C. Kurachi

  • M. Chen

  • D. Kumar

  • T.K. Waddell

  • L.G. Singer

  • S. Keshavjee

  • A. Humar

  • J. Feld

Medical Centers

  • Paulista University, Sao Paulo, Brazil

  • Toronto Western Hospital, Toronto, ON, Canada

Locations

  • Brazil

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis C

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved